Home/ Stocks/ FTH

Faeth Therapeutics, Inc. Common Stock

FTH XNAS

$24.39 -0.09 (-0.37%) ▼ 15-min delayed

Open

$24.60

High

$25.40

Low

$24.06

Volume

202.8K

Market Cap

$631.06M

About Faeth Therapeutics, Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 29 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-16,007,000	$-2.84

Related Market News

No specific coverage for FTH yet. Check out our latest market news or earnings calendar.

Get FTH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Faeth Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.